The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
The H19 Non-Coding RNA Is Essential for Human Tumor Growth
Open accessAbstract
BACKGROUND: Mutations and epigenetic aberrant signaling of growth factors pathways contribute to carcinogenesis. Recent studies reveal that non-coding RNAs are controllers of gene expression. H19 is an imprinted gene that demonstrates maternal monoallelic expression without a protein product; although its expression is shut off in most tissues postnatally, it is re-activated during adult tissue regeneration and tumorigenesis. Moreover, H19 is highly expressed in liver metastasis derived from a range of carcinomas. The objective of this study is to explore the role of H19 in carcinogenesis, and to determine its identification as an anti-tumor target. METHODOLOGY/PRINCIPLE FINDINGS: By controlling oxygen pressure during tumor cell growth and H19 expression levels, we investigated the role of H19 expression in vitro and in vivo in hepatocellular (HCC) and bladder carcinoma. Hypoxia upregulates the level of H19 RNA. Ablations of tumorigenicity of HCC and bladder carcinomas in vivo are seen by H19 knockdown which also significantly abrogates anchorage-independent growth after hypoxia recovery, while ectopic H19 expression enhances tumorigenic potential of carcinoma cells in vivo. Knocking-down H19 message in hypoxic stress severely diminishes p57(kip2) induction. We identified a number of potential downstream targets of H19 RNA, including angiogenin and FGF18. CONCLUSIONS: H19 RNA harbors pro-tumorigenic properties, thus the H19 gene behaves as an oncogene and may serve as a potential new target for anti-tumor therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,483
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Self-citationc-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Rational siRNA design for RNA interference
Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., & Khvorova, A. (2004) · Nature Biotechnology · doi:10.1038/nbt936 · Cited by 2,094
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Sells, M. A., Chen, M. L., & Acs, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.4.1005 · Cited by 1,117
Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy.
Rodesch, F., Simon, P., Donner, C., & Jauniaux, E. R. M. (1992) · PubMed · Cited by 753
The imprinted H19 noncoding RNA is a primary microRNA precursor
Cai, X., & Cullen, B. R. (2007) · RNA · doi:10.1261/rna.351707 · Cited by 642
Tumour-suppressor activity of H19 RNA
Hao, Y., Crenshaw, T., Moulton, T., Newcomb, E., & Tycko, B. (1993) · Nature · doi:10.1038/365764a0 · Cited by 630
Invasive growth: a MET-driven genetic programme for cancer and stem cells
Boccaccio, C., & Comoglio, P. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1912 · Cited by 538
Chaumeil, J., Le Baccon, P., Wutz, A., & Heard, E. (2006) · Genes & Development · doi:10.1101/gad.380906 · Cited by 529
Caveolin-1 in oncogenic transformation, cancer, and metastasis
Williams, T. M., & Lisanti, M. P. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00458.2004 · Cited by 511
TLR-4 Signaling Promotes Tumor Growth and Paclitaxel Chemoresistance in Ovarian Cancer
Kelly, M. G., Alvero, A. B., Chen, R., Silasi, D.-A., Abrahams, V. M., Chan, S., Visintin, I., Rutherford, T., & Mor, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3948 · Cited by 488
Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling
Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A., & Fässler, R. (2006) · Cell · doi:10.1016/j.cell.2006.03.041 · Cited by 476
Barsyte-Lovejoy, D., Lau, S. K., Boutros, P. C., Khosravi, F., Jurisica, I., Andrulis, I. L., Tsao, M. S., & Penn, L. Z. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0037 · Cited by 461
IEX -1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell Survival
Wu, M. X., Ao, Z., Prasad, K. V. S., Wu, R., & Schlossman, S. F. (1998) · Science · doi:10.1126/science.281.5379.998 · Cited by 413
Kaposi-Novak, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27236 · Cited by 398
Role of B61, the Ligand for the Eck Receptor Tyrosine Kinase, in TNF-α-Induced Angiogenesis
Pandey, A., Shao, H., Marks, R. M., Polverini, P. J., & Dixit, V. M. (1995) · Science · doi:10.1126/science.7536959 · Cited by 363
Berteaux, N., Lottin, S., Monté, D., Pinte, S., Quatannens, B., Coll, J., Hondermarck, H., Curgy, J.-J., Dugimont, T., & Adriaenssens, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504033200 · Cited by 362
Genetics of hepatocellular tumors
Laurent-Puig, P., & Zucman-Rossi, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209547 · Cited by 317
Epigenetic lesions at the H19 locus in Wilms' tumour patients
Moulton, T., Crenshaw, T., Hao, Y., Moosikasuwan, J., Lin, N., Dembitzer, F., Hensle, T., Weiss, L., McMorrow, L., Loew, T., et al. (1994) · Nature Genetics · doi:10.1038/ng0794-440 · Cited by 316
Expression Profiling in Ovarian Clear Cell Carcinoma
Tsuchiya, A., Sakamoto, M., Yasuda, J., Chuma, M., Ohta, T., Ohki, M., Yasugi, T., Taketani, Y., & Hirohashi, S. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63605-x · Cited by 308
Matsuoka, S., Thompson, J. S., Edwards, M. C., Bartletta, J. M., Grundy, P., Kalikin, L. M., Harper, J. W., Elledge, S. J., & Feinberg, A. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.3026 · Cited by 301
Human Tribbles, a Protein Family Controlling Mitogen-activated Protein Kinase Cascades
Kiss-Toth, E., Bagstaff, S. M., Sung, H. Y., Jozsa, V., Dempsey, C., Caunt, J. C., Oxley, K. M., Wyllie, D. H., Polgar, T., Harte, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407732200 · Cited by 300
Akt Signaling and Cancer: Surviving but not Moving On
Toker, A., & Yoeli-Lerner, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0743 · Cited by 295
Puisieux, A., Lim, S.-K., Groopman, J. D., & Öztürk, M. (1991) · PubMed · Cited by 259
Iizuka, N., Oka, M., Yamada‐Okabe, H., Mori, N., Tamesa, T., Okada, T., Takemoto, N., Tangoku, A., Hamada, K., Nakayama, H., et al. (2002) · PubMed · Cited by 245
The H19 gene: regulation and function of a non-coding RNA
Gabory, A., Ripoche, M.-A., Yoshimizu, T., & Dandolo, L. (2006) · Cytogenetic and Genome Research · doi:10.1159/000090831 · Cited by 227
The Id proteins and angiogenesis
Benezra, R., Rafii, S., & Lyden, D. (2001) · Oncogene · doi:10.1038/sj.onc.1205160 · Cited by 222 · cited 1×
“H19 RNA knockdown affects the hypoxic responsiveness of the potent angiogenic factors ANG [41], FGF18 [42], prolylcarboxypeptidase (PRCP) or angiotensinase c [43], tumor necrosis factor, alphainduced protein 1 (endothelial) (TNFAIP1) also known as (B61) [44] Calponin2 (CNN2) [45] and inhibitor of DNA binding 2 (Id2) […”
BackgroundInhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4.
Ito, Y., Oike, Y., Yasunaga, K., Hamada, K., Miyata, K., Matsumoto, S.-I., Sugano, S., Tanihara, H., Masuho, Y., & Suda, T. (2003) · PubMed · Cited by 220
Liu, Z., Lavine, K. J., Hung, I. H., & Ornitz, D. M. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.071 · Cited by 203
Buscà, R., Berra, E., Gaggioli, C., Khaled, M., Bille, K., Marchetti, B., Thyss, R., Fitsialos, G., Larribère, L., Bertolotto, C., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501067 · Cited by 178
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
Pelosi, G., Pastorino, U., Pasini, F., Maissoneuve, P., Fraggetta, F., lannucci, A., Sonzogni, A., De Manzoni, G., Terzi, A., Durante, E., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600731 · Cited by 174
Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer
Rubin, M. A., Varambally, S., Beroukhim, R., Tomlins, S. A., Rhodes, D. R., Paris, P. L., Hofer, M. D., Storz-Schweizer, M., Kuefer, R., Fletcher, J. A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3881 · Cited by 168
Angiogenin antagonists prevent tumor growth in vivo.
Olson, K. A., Fett, J. W., French, T. C., Key, M. E., & Vallee, B. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.442 · Cited by 159
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma
Ariel, I. (2000) · Molecular Pathology · doi:10.1136/mp.53.6.320 · Cited by 146
Functional Genomics of Hepatocellular Carcinoma
Thorgeirsson, S. S., Lee, J., & Grisham, J. W. (2006) · Hepatology · doi:10.1002/hep.21063 · Cited by 137
Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma.
Ariel, I. M., Miao, H., Ji, X., Schneider, T., Roll, D., de Groot, N., Hochberg, A., & Ayesh, S. K. (1998) · Molecular Pathology · doi:10.1136/mp.51.1.21 · Cited by 125
Self-citationPossible physiological role of H19 RNA
Ayesh, S. K., Matouk, I., Schneider, T., Ohana, P., Laster, M., Al-Sharef, W. A., de-Groot, N., & Hochberg, A. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10075 · Cited by 120
Self-citationGuéhenneux, F., Duret, L., Callanan, M. B., Bouhas, R., Hayette, S., Berthet, C., Samarut, C., Rimokh, R., Birot, A., Wang, Q., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400599 · Cited by 119
Identification of a new tumor suppressor gene located at chromosome 8p21.3–22
Seibold, S., Rudroff, C., Weber, M. F. A., Galle, J., Wanner, C., & Marx, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0934fje · Cited by 115
The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53
Dugimont, T., Montpellier, C., Adriaenssens, É., Lottin, S., Dumont, L., Iotsova, V., Lagrou, C., Stéhelin, D., Coll, J., & Curgy, J. (1998) · Oncogene · doi:10.1038/sj.onc.1201742 · Cited by 114
Discovery and Clinical Application of a Novel Prostate Cancer Marker
Jiang, Z., Woda, B. A., Wu, C., & Yang, X. J. (2004) · American Journal of Clinical Pathology · doi:10.1309/ejuyuqpex1mg68mk · Cited by 112
Nozaki, S., Sledge, G. W., & Nakshatri, H. (2001) · Oncogene · doi:10.1038/sj.onc.1204292 · Cited by 109
Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2
Meyer, A. M., Dwyer-Nield, L. D., Hurteau, G. J., Keith, R. L., O'Leary, E., You, M., Bonventre, J. V., Nemenoff, R. A., & Malkinson, A. M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh150 · Cited by 104
Cao, X., Qin, J., Xie, Y., Khan, O. Y., Dowd, F. J., Scofield, M., Lin, M.-F., & Tu, Y. (2006) · Oncogene · doi:10.1038/sj.onc.1209408 · Cited by 99
Zhao, Y., Qiu, Q., Mahdi, F., Shariat‐Madar, Z., Røjkjær, R., & Schmaier, A. H. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.4.h1821 · Cited by 93
CD4+CXCR4highCD69+ T Cells Accumulate in Lung Adenocarcinoma
Wald, O., Izhar, U., Amir, G., Avniel, S., Bar-Shavit, Y., Wald, H., Weiss, I. D., Galun, E., & Peled, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6983 · Cited by 93
Self-citationA Tumor Progression Model for Hepatocellular Carcinoma: Bioinformatic Analysis of Genomic Data
Poon, T. C. W., Wong, N., Lai, P. B. S., Rattray, M., Johnson, P. J., & Sung, J. J. �. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.014 · Cited by 88
Katzenellenbogen, M., Pappo, O., Barash, H., Klopstock, N., Mizrahi, L., Olam, D., Jacob‐Hirsch, J., Amariglio, N., Rechavi, G., Mitchell, L. A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2937 · Cited by 83
Self-citationDatta, K., Li, J., Bhattacharya, R., Gasparian, L., Wang, E., & Mukhopadhyay, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2706 · Cited by 68
A Critical Role for Calponin 2 in Vascular Development
Tang, J. X., Hu, G., Hanai, J.-I., Yadlapalli, G., Lin, Y., Zhang, B., Galloway, J. L., Bahary, N., Sinha, S., Thisse, B., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506991200 · Cited by 65
Coulouarn, C., Gómez-Quiroz, L. E., Lee, J., Kaposi-Novák, P., Conner, E. A., Goldina, T. A., Онищенко, Г. Е., Factor, V. M., & Thorgeirsson, S. S. (2006) · Hepatology · doi:10.1002/hep.21293 · Cited by 64
Moreno, M., Ball, M., Andrade, M. F., McDermid, A., & Stanimirovic, D. B. (2006) · Glia · doi:10.1002/glia.20345 · Cited by 49
Adriaenssens, É., Lottin, S., Berteaux, N., Hornez, L., Fauquette, W., Fafeur, V., Peyrat, J., Bourhis, X. L., Hondermarck, H., Coll, J., et al. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5500 · Cited by 46
Dugimont, T., Curgy, J., Wernert, N., Delobelle, A., Raes, M., Joubel, A., Stéhelin, D., & Coll, J. (1995) · Biology of the Cell · doi:10.1016/0248-4900(96)85272-5 · Cited by 42
Smith, P. J., Syed, N., & Crook, T. (2006) · Cell Cycle · doi:10.4161/cc.5.12.2813 · Cited by 41
Cited by
Long Noncoding RNA and Cancer: A New Paradigm
Bhan, A., Soleimani, M., & Mandal, S. S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2634 · Cited by 2,861
The emerging role of lncRNAs in cancer
Huarte, M. (2015) · Nature Medicine · doi:10.1038/nm.3981 · Cited by 2,702
The Emergence of lncRNAs in Cancer Biology
Prensner, J. R., & Chinnaiyan, A. M. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0209 · Cited by 1,770
The functional role of long non-coding RNA in human carcinomas
Gibb, E. A., Brown, C. J., & Lam, W. L. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-38 · Cited by 1,619
Roles, Functions, and Mechanisms of Long Non-Coding RNAs in Cancer
Fang, Y., & Fullwood, M. J. (2016) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2015.09.006 · Cited by 1,069
Metadata
- Authors
- Matouk, I. J., DeGroot, N., Mezan, S., Ayesh, S., Abu-lail, R., Hochberg, A., & Galun, E.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-09-05
- Volume
- 2
- Issue
- 9
- Pages
- e845
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2049536473
- Cited by
- 650
- References
- 62
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.